CH:SANN / Santhera Pharmaceuticals Holding AG - 机构投资人持股 - 买家

Santhera 制药控股公司

CH ˙ SWX ˙ CH1276028821

CHF14.78 ↑0.20 (1.37%)

2025-09-12
分享价格

机构和基金投资人持股 - 买家

在Santhera 制药控股公司中开设新头寸的主要持有者包括 AVDV - Avantis 国际小盘价值 ETF, AVDE - Avantis 国际股票 ETF, OWSMX - 老韦斯特伯里中小型股策略基金, AVDEX - Avantis 国际股票基金机构类, 和 IBRN - iShares 神经科学和医疗保健 ETF .

本页面显示了上一报告期内增持或开仓的上市机构、基金和大股东的股权结构变化绿色行表示新头寸。点击链接图标查看完整的交易历史记录。

升级以解锁高级数据。

文件日期	来源	投资者		类型	平均价格 (Est)	股份	Δ 股份 (%)	报告价值 ($1000)	Δ 价值 (%)	投资组合配置 (%)
2025-07-28	NP	AVDV - Avantis 国际小盘价值 ETF This fund is a listed as child fund of American Century Companies Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value				5,070		80
2025-07-28	NP	AVDEX - Avantis 国际股票基金机构类 This fund is a listed as child fund of American Century Companies Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value				1,169		19
2025-03-28	NP	OWSMX - 老韦斯特伯里中小型股策略基金				2,068		39
2025-06-26	NP	IBRN - iShares 神经科学和医疗保健 ETF				870		15
2025-06-26	NP	DXIV - Dimensional International Vector 股票 ETF				142	8.40	3	0.00
2025-07-28	NP	AVDE - Avantis 国际股票 ETF This fund is a listed as child fund of American Century Companies Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value				2,534		40

Other Listings

GB:SANNZ
US:SPHDF
GB:0QN1	CHF14.58

Fintel data has been cited in the following publications:

© 2015-2025 Fintel Ventures LLC. All rights reserved. Fintel® is a registered trademark.

This website is provided “as is” without any representations or warranties, express or implied. Fintel makes no representations or warranties in relation to this website or the information and materials provided on this website. Nothing on this website constitutes, or is meant to constitute, advice of any kind. If you require advice in relation to any financial matter you should consult an appropriate professional.